secwatch.observer — SEC 8-K summary
======================================

Issuer:     DEXCOM INC (DXCM)
CIK:        0001093557
Form:       8-K
Filed at:   2023-05-03T23:59:59+00:00
Accession:  0001193125-23-133137
Event type: debt
Sentiment:  neutral
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DexCom prices upsized $1.1B 0.375% convertible notes due 2028; repurchases $188.7M of stock
--------------------------------------------------------------------------------

- Offering raised to $1.1B from initially announced $1.0B; initial purchasers have 13-day option for additional $150M.
- Notes carry 0.375% coupon, mature May 15, 2028; initial conversion price ~$162.41/share (37.5% premium over May 2 close of $118.12).
- Net proceeds ~$1.08B ($1.23B if option exercised); $188.7M used to repurchase 1.6M shares at $118.12 concurrent with offering.
- $89.1M allocated to capped call transactions to reduce potential dilution; remainder for capex, working capital, and general purposes.
- Notes are unsecured, non-redeemable before May 20, 2026; holders can require repurchase upon a fundamental change.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1093557/000119312523133137/0001193125-23-133137-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1093557/000119312523133137/d488055d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-133137

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer